Cite
HARVARD Citation
Giugliano, D. et al. (2019). GLP‐1 receptor agonists for prevention of cardiorenal outcomes in type 2 diabetes: An updated meta‐analysis including the REWIND and PIONEER 6 trials. Diabetes, obesity & metabolism. 21 (11), pp. 2576-2580. [Online].